1892

Nobel laureate and the father ofimmunology Dr. Paul Ehrlich proposes the "maternal immunity” theory

1950

Dr. William Earl Petersen published the clinical report demonstrating that immune milk improves arthritis and allergic disease symptoms

1958

Mr. Ralph Stolle was inspired by Paul Ehrlich and William Earl Petersen to invest heavily in Stolle immune milk research

1960

Stolle immune milk production begins in Lebanon, Ohio followed by the launch of a large-scale open-label trial in humans (The Ohio Survey), lasting for nearly thirty years

1961

The State of Ohio agreed to allow the sale of Stolle immune milk

1970

The beginning of a series of large-scale scientific research projects involving human clinical trials, animal studies and sophisticated laboratory studies

1981

After many long-term studies, Stolle immune milk was awarded 250 patents in 27 countries covering 10 categories

1987

Stolle and the New Zealand Dairy Board (NZDB) worked jointly to develop, manufacture and market Stolle immune milk

1990

Research results have been performed and published in major international scientific journals, while research programs studying the efficacy and mechanisms of Stolle immune milk continue in the United States, Japan and Taiwan

1992

Stolle is first marketed in Taiwan

1995

Stolle expands marketing effort into Japan

1997

Stolle is introduced into Malaysia

2003

Stolle expands marketing into China

2004

Stolle products achieve US FDA Generally Recognized As Safe (GRAS) affirmation

2008

Stolle complex formula is introduced into Japan

2012

Stolle infant formula is first marketed in China

2015

Stolle Improved Infant Formula is produced in Europe

Future

Stolle immune milk has become the world's leading brand and we will continue our mission to "enhance the quality of human life"